← The Wire
BBOTNasdaq
BridgeBio Oncology Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1869105
Develops oncology therapies for cancers driven by RAS and PI3Ka oncogenes
red 8-K · 90d
$621M
Market cap
$7.66
Last close
+3.5%
1D
-2.7%
5D
236K
Volume
Price · last 39 sessions-9.5%
May 4L $7.12 · H $9.11Jun 29
48
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 22, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 20268-KExecutive ChangeApr 29, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KExecutive Change · Reg FD DisclosureApr 23, 20268-KExecutive ChangeMar 26, 202610-K10-KMar 5, 20268-KResults of OperationsMar 5, 20268-KCompany UpdateJan 7, 202610-Q10-QNov 12, 20258-KResults of OperationsNov 12, 2025S-1S-1Aug 29, 20258-KAuditor Change · Change of ControlAug 13, 20258-KReg FD DisclosureAug 6, 2025425CURRENT REPORTAug 4, 20258-KShareholder VoteAug 4, 202510-QQUARTERLY REPORTAug 1, 2025425FORM 425Jul 21, 2025425CURRENT REPORTJul 11, 20258-KReg FD DisclosureJul 11, 2025424B4PROSPECTUSJul 10, 2025S-4REGISTRATION STATEMENTJun 20, 202510-QQUARTERLY REPORTMay 15, 202510-KANNUAL REPORTMar 11, 2025425FORM 425Mar 6, 2025425CURRENT REPORTMar 3, 20258-KMaterial Agreement · Equity IssuanceMar 3, 2025425CURRENT REPORTFeb 28, 20258-KReg FD DisclosureFeb 28, 20258-KExecutive ChangeFeb 10, 202510-QQUARTERLY REPORTNov 14, 2024SC 13GSC 13GNov 14, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GOct 22, 202410-QQUARTERLY REPORTAug 14, 202410-QQUARTERLY REPORTMay 15, 2024SC 13GHELIX ACQUISITION CORP. IIFeb 23, 2024SC 13GSC 13GFeb 23, 2024SC 13DSCHEDULE 13DFeb 20, 20248-KCompany UpdateFeb 20, 2024SC 13GSC 13GFeb 15, 20248-KExecutive Change · Material AgreementFeb 14, 2024424B4PROSPECTUSFeb 13, 2024S-1/AREGISTRATION STATEMENTFeb 7, 2024S-1/AREGISTRATION STATEMENTFeb 2, 2024S-1REGISTRATION STATEMENTJan 18, 2024
Similar companies
Comparable business profile · signals at a glance